Schonfeld Strategic Advisors LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1665241
NEW YORK, NY
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,904,646
-$9,393,765 QoQ
Shares Held
103,192
-59.9% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#142
of 561 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Derivatives in BMRN
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$867,104
PutShares
9,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. BMRN ranks #19 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,904,646 | 103,192 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $15,298,411 | 257,419 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,747,555 | 475,398 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,706,590 | 231,155 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,581,290 | 262,856 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $729,603 | 11,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,154,247 | 30,648 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,830,886 | 204,432 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,938,851 | 182,492 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,503,247 | 171,160 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,405,688 | 95,001 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $867,104 | 9,800 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $5,896 | 32,400 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $5,064,452 | 58,427 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $199,990 | 51,800 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $1,253,131 | 12,887 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,274,001 | 70,287 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,210,483 | 96,856 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $231,455 | 2,793 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,945,220 | 38,200 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $2,264,597 | 29,300 | Shares | Sole | 2021-11-16 | |
| 2020-12-31 | $1,625,860 | 18,541 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $361,608 | 4,753 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,170,249 | 9,488 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $536,575 | 6,350 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||